Patents by Inventor Holly S. Vitense

Holly S. Vitense has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220193419
    Abstract: Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.
    Type: Application
    Filed: March 9, 2022
    Publication date: June 23, 2022
    Inventors: Shantanu Sarkar, Douglas A. Hettrick, Amul Y. Desai, Randolph M. Biallas, Holly S. Vitense, Jodi L. Redemske
  • Publication number: 20180126172
    Abstract: Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 10, 2018
    Inventors: Shantanu Sarkar, Douglas A. Hettrick, Amul Y. Desai, Randolph M. Biallas, Holly S. Vitense, Jodi L. Redemske
  • Publication number: 20160361026
    Abstract: Techniques for using multiple physiological parameters to provide an early warning for worsening heart failure are described. A system is provided that monitors a multiple diagnostic parameters indicative of worsening heart failure. The parameters preferably include are least one parameter acquired from an implanted device, such as intrathoracic impedance. The system device derives an index of the likelihood of worsening heart failure based upon the parameters using a Bayesian approach and displays the resultant index for review by a physician.
    Type: Application
    Filed: March 29, 2011
    Publication date: December 15, 2016
    Applicant: Medtronic, Inc.
    Inventors: Shantanu Sarkar, Douglas A. Hettrick, Amul Y. Desai, Randolph M. Biallas, Holly S. Vitense, Jodi L. Redemske
  • Patent number: 8948868
    Abstract: The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: February 3, 2015
    Assignee: Medtronic, Inc.
    Inventors: Holly S. Vitense, Li Wang, Denise Dirnberger, Melissa M. Rhodes, Douglas A. Hettrick, Shantanu Sarkar
  • Publication number: 20120303085
    Abstract: The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.
    Type: Application
    Filed: August 9, 2012
    Publication date: November 29, 2012
    Applicant: Medtronic, Inc.
    Inventors: Holly S. Vitense, Li Wang, Denise Dirnberger, Melissa M. Rhodes, Douglas A. Hettrick, Shantanu Sarkar
  • Patent number: 7496409
    Abstract: An implantable medical device system and method are provided for monitoring the quality of signals sensed by a subcutaneously implanted device using subcutaneous electrodes. In one embodiment, the method includes selecting one or more sensing vectors; sensing signals from selected sensing vectors, determining a signal quality metric in response to a sensed signal, comparing the signal quality metric to a predetermined threshold, and generating a loss of signal quality response in response to the signal quality crossing the threshold.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: February 24, 2009
    Assignee: Medtronic, Inc.
    Inventors: Saul E. Greenhut, Robert W. Stadler, Holly S. Vitense
  • Publication number: 20080103530
    Abstract: The capability to suspend a patient alert relating to a monitored physiologic parameters addresses a need to selectively shut off a patient-alert signal or signals during the time a patient is being treated for an excursion in the parameter. Of course, in general a signal call attention to a patient's a potentially deleterious status or condition for which they should seek medical attention. Once a chronically-implanted monitoring device has detected or provided information about the parameter relative to a desired value, trend, or range and a clinician has been notified and intervened the alert signal is temporarily disabled for a predetermined period. That is, once the notification occurs and alert has served its purpose, the alert mechanism is selectively deactivated while the patient ostensibly begins to gradually correct the monitored physiologic parameter under a caregiver's direction and control. After which time, the alert will reactivate.
    Type: Application
    Filed: October 31, 2006
    Publication date: May 1, 2008
    Inventors: Holly S. Vitense, Li Wang, Denise Dirnberger, Melissa M. Rhodes, Douglas A. Hettrick, Shantanu Sarkar
  • Patent number: 7265676
    Abstract: An alert system for alerting a clinician to an occurrence of an event detected by an implantable medical device includes a monitor and a patient management network. The implantable medical device includes a means for detecting the occurrence of the event and initiating a wireless transmission of data related to the event. The monitor is configured to receive the wireless transmission of data and transfer the data. The patient management network is configured to receive the data and store the data on a data storage device. The patient management network includes a web presentation service for creating a website from the data stored on the data storage device, the website configured to alert the clinician to the occurrence of the event.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: September 4, 2007
    Assignee: Medtronic, Inc.
    Inventors: Paul G. Gordon, Javaid Masoud, James J. Ball, Holly S. Vitense, James E. Willenbring, John P. Vandanacker, Sean B. McAdams, Dean A. Hooper